Ask Warren

Eye Gene

185490 · KOSDAQ · ₩185490 · 아이진

₩1,705▼ ₩45 (2.57%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.3B₩1.3B₩774M₩1.1B₩877M₩818M₩1.3B₩960M
Cost of sales₩1B₩919M₩528M₩777M₩597M₩550M₩975M₩658M
Gross profit₩326M₩353M₩246M₩320M₩281M₩268M₩337M₩302M
Operating income−₩3.9B−₩3.5B−₩3.3B−₩1.6B−₩2.5B−₩2.5B−₩2.4B−₩3.6B
Net income−₩3.8B−₩3.6B−₩12B−₩1.6B−₩2.4B−₩3.1B−₩2.7B−₩3.6B
Net income to shareholders−₩3.8B−₩3.5B−₩8.8B−₩1.5B−₩2.3B−₩3.1B−₩2.8B−₩3.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩61B₩65B₩68B₩57B₩61B₩63B₩65B₩68B
Current assets₩41B₩44B₩48B₩28B₩32B₩34B₩35B₩37B
Cash and equivalents₩4.1B₩7.2B₩10B₩2.9B₩2.4B₩2.8B₩1.4B₩500M
Total liabilities₩14B₩14B₩14B₩13B₩15B₩15B₩14B₩14B
Current liabilities₩10B₩10B₩10B₩8.8B₩11B₩12B₩11B₩6.7B
Borrowings₩3B₩3B₩3.3B₩2.4B₩1.9B₩1.8B₩1.8B₩1.7B
Total equity₩47B₩51B₩54B₩44B₩46B₩48B₩51B₩53B
Shareholders' equity₩50B₩54B₩57B₩44B₩45B₩48B₩50B₩53B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3B−₩3.1B−₩2.4B−₩904M−₩2B−₩642M−₩1.7B−₩1.5B
Capital spending₩25M₩6.2M₩400,000₩65M₩34M₩4M₩203M₩438M
Free cash flow−₩3B−₩3.1B−₩2.4B−₩969M−₩2B−₩646M−₩1.9B−₩2B

Consolidated where available. Amounts in won.

Also known as: Eye Gene / 아이진 / 185490 / KRX:185490

Source: KRX statistical information